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When cells are exposed to a variety of stimuli, there is increased expression of stress 
or heat shock proteins, a major representative of which is hsp70. The objective of the present 
work was to investigate the endogenous expression of hsp70 in peripheral blood mono­
nuclear cells and erythrocytes of patients suffering from b-thalassaemia and to correlate 
hsp70 levels with patients' antioxidant status. Blood samples were obtained from 
thalassaemia major patients aged 16-24 years. Hsp70 was identified with a mouse mono­
clonal anti-human hsp70 antibodies using the Western blot procedure. The total antioxi­
dant status was determined by means of a commercial kit of RANDOX. It was established 
that: i) Hsp70 levels were low in mononuclear cells, ii) Hsp70 was not appreciably induced 
by incubation at 43°C, Hi) in erythrocytes, however, there was a marked endogenous ex­
pression ofhsp70 - thalassaemics express more hsp70 than control subjects, iv) the antioxi­
dant status of thalassaemics was by about 20 % less than the control one. The increased 
endogenous hsp70 in thalassaemic erythrocytes was consistent with the hypothesis that the 
elevated levels of denaturated globins induced the expression of stress proteins during 
erythopoiesis. We are currently investigating whether there is a correlation between the 
severity of the clinical symptoms and hsp70 levels. 
blood cell transfusions combat the 
anaemia but result in accumulation of 
tissue iron which if untreated is fatal in 
the second decade of life. The develop­
ment of iron chelation therapy has led 
to dramatic improvements in survival 
and quality of life. Iron overload is, 
however, still a major concern. Under 
physiological conditions ferric ions are 
bound to proteins (transferrin and fer­
ritin) and are not available to catalyse 
the conversion of molecular oxygen to 
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Homozygous b-thalassaemia is 
haracterized by absent or reduced pro­
duction of haemoglobin b-chains. The 
haemoglobin а-chains which remain in 
excess aggregate in insoluble homotetr-
amers which precipitate intracellular^ 
leading to premature red cell destruc­
tion (haemolytic anaemia). Regular red 
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reactive oxygen species ( R O S ) , e. g., 
hydroxyl ions, superoxide and hydro­
gen peroxide. Under conditions of iron 
overload such as thalassaemia, how­
ever, there is an increase of low-molecu­
lar weight iron w h i c h promotes 
peroxidative damage and cell injury 
(4,5) and causes a decreased total anti­
oxidant status of the patient (10). 
When cells are exposed to a 
variety of stimuli (physiopathologic 
conditions and environmental assaults, 
including oxidative stress), there is an 
increased expression of certain classes 
of proteins, the so-called stress or heat 
shock proteins, a major representative 
of which is hsp70, which protect cellu­
lar proteins from denaturation (8). The 
human hsp70 family includes 11 genes 
expressed either const i tu t ively 
(hsp70c), or after induction by various 
agents (hsp70i). Although the expres­
sion of hsp70 has been studied in vari­
ous haemopoietic cells, there is no in­
formation about its expression in the 
white and red blood cells of patients suf­
fering from iron overload. We reasoned 
that the increased iron levels found in 
b-thalassaemia would result in in­
creased R O S formation and expression 
of hsp70. This stress response might 
confer considerable protection to red 
blood cells because it could decrease 
the effective concentration of free hae­
moglobin а-chains through association 
with hsp70, and to white blood cells 
which may become more able to with­
stand the damaging effects of R O S . 
The objective of the present 
study was to investigate the endogenous 
expression of hsp70 in peripheral blood 
mononuclear cells and erythrocytes of 
patients suffering from b-thalassaemia 
and to correlate hsp70 levels with pa­
tients' antioxidant status. 
MATERIAL AND METHODS 
Blood samples were obtained 
from patients aged 16-24 years and suf­
fering from thalassaemia major who 
were on Desferrioxamine treatment just 
before blood transfusion. Samples from 
age-matched blood donors were used 
as normal controls. Peripheral blood 
mononuclear cells and erythrocytes 
were obtained by density centrifugation 
of whole blood-EDTA samples through 
F i c o l l . The cel ls were extensively 
washed with H A N K S and then resus-
pended in R P M I 1640 containing 10 % 
fetal calf serum, 1 % glutamine, and 
penicillin-streptomycin. The cells were 
preincubated at 37°C for 2 hours, heat-
shocked at 43°C for 2 hours, and al­
lowed to recover at 37°C for 1 hour. Af­
ter pelleting and washing, they were ly-
sed in triple detergent buffer, boiled in 
x2 Laemmli sample buffer (6) and the 
proteins were separated by S D S - P A G E 
and transferred to nitrocellulose filters. 
Hsp70 was identified by probing with 
a mouse monoclonal anti-human hsp70 
antibody (Sigma H5147) which detects 
both constitutive and inducible forms. 
Colour was developed after the addi-
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n of a reporter anti-mouse IgG-HPR 
antibody using a horseradish peroxidase 
chromogen solution. Human hsp70 
(Sigma) was used as positive control. 
Patients' total antioxidant status was de­
termined in serum samples by follow­
ing the absorption of the radical cation 
A B T S (10) using a kit by R A N D O X . 
I ther clinical chemical analyses were 
performed at the Larissa Hospital D i ­
agnostic Laboratories, Larissa. 
ESULTS AND DISCUSSION 
Fig. 1 shows the expression of 
hsp70 in the white and red blood cells 
of eight thalassaemic and six control 
subjects. They are representative of the 
Western blots obtained with several dif-
ferent samples. 
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Fig. 1. Expression ofhsp70 in white and red 
blood cells of normal and thalassaemic 
subjects 
We find out that in peripheral 
blood mononuclear cells: i ) endogenous 
hsp70 levels, i i ) hsp70 is not apprecia­
bly induced by incubation at 43°C, i i i ) 
thalassaemic cells express even less 
hsp70 than control ones when equal 
amounts of proteins are loaded, iv ) 
R N A extracted from mononuclear cells 
of normal and thalassaemic subjects 
also give a very faint signal for hsp70m 
R N A on Northern blots (results not 
shown). In erythrocytes, however, there 
is a marked endogenous expression of 
hsp70. Thalassaemics express more 
hsp70 than control subjects. 
The total antioxidant status of 
the serum of thalassaemic subjects is 
by approximately 20 % less than that 
of normal subjects (Table 1). 
Table 1 
Total antioxidant status of control and 
thalassaemic subjects 
(Each value represents the mean ±SD) 
Subjects m M / L 
Control (n=8) 1,49 ±0,17 
Thalassaemic (n=8) 1,21 ±0,16 
(p < 0,1 by Student's Mest). 
The mean values of selected 
haematologic indices for the 
thalassaemic and control individuals are 
the following (Table 2): 
Table 2 
Haematologic parameters of control 
and thalassaemic subjects 
Parameters T С 
g % haemoglobin 10,2 14,3 
g/mliron 260,0 110,0 
ng/ml ferritin 1,890 82 
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In haemopoietic cells the ex­
pression of hsp70 has been studied in 
chicken, rabbit, murine and human cells 
and in various leukaemic cell lines 
(2,3). It has been found that monocytes 
and granulocytes, but not lymphocytes, 
constitutively express hsp70 (2). Act i ­
vation of either lymphocytes or mono­
cytes by cytokines or exposure to oxi­
dative stress leads to induction or in­
creased expression of hsp70 (9). Its ex­
pression is induced during erythroid cell 
differentiation (1) and increases further 
by heat shock. 
Our results with the mono­
nuclear cells (which consist of approxi­
mately 85 % lymphocytes and 15 % 
monocytes) agree with the findings in 
the literature available about the low 
levels of endogenous hsp70 expression. 
The fact that we could not find any in­
crease of hsp70 levels in the 
thalassaemic white cells was unex­
pected, given increased patients' iron 
and ferritin levels and the decreased 
serum antioxidant capacity. It suggests 
that the presumed oxidative stress 
either does not affect mononuclear cells, 
or is compensated by other mecha­
nisms. The increased endogenous hsp70 
in thalassaemic erythrocytess, however, 
is consistent with the hypothesis that the 
elevated levels of denaturated globins 
induce the expression of stress proteins 
during erythropoiesis. Finally, this 20 
% decrease of the antioxidant status of 
the thalassaemic patients is comparable 
to the 14 % one reported in another 
study (7). 
We are currently investigating 
whether there is a correlation between 
the severity of the clinical symptoms 
and hsp70 levels. 
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Резюме: Когато клетката се подложи на редица външни и вътрешни въздействия 
рязко се увеличава експресията на т.н. стресови или топлинно-шокови протеини 
(ТШП). Счита се, че главна роля тук играят ТШП-70. Цел на настоящото изследване 
бе да се докаже ендогенната поява на ТШП-70 в еритроцити и мононуклеарни клетки 
на болни с b-таласемия. Проби от кръвта на болни на възраст от 16 до 24 г. бяха 
получени от градската болница в Лариса, Гърция. ТШП-70 бяха идентифицирани 
чрез моноклонални антитела. Антиоксидантният статус на болните бе определен с 
помощта на кит от фирмата RANDOX. Получените резултати показват, че: 1) нивото 
на ТШП-70 в мононуклеарните клетки е много ниско; 2) допълнителният топлинен 
шок на клетките при 43°С не повишава значимо изходното ниво; 3) при еритроцитите 
се наблюдава значителна експресия на ТШП-70 в сравнение с контролата, 4) 
антиоксидантният статус на болните е с около 20 % по-нисък в сравнение с контролата. 
Повишеното ниво на ТШП-70 в таласемични червени кръвни клетки е в съзвучие с 
хипотезата, че големите количества денатуриран глобин може да индуцира 
експресията на стресови протеини по време на еритропоезата. В ход са сравнителни 
изследвания между тежестта на клиничната картина и нивата на ТШП-70 при болни 
с таласемия. 
